"Current Covid variants transmissible but not severe": Dr Arjun Dang
New Delhi [India], May 28 (ANI): The number of COVID-19 cases in India reached 1,010, on May 27. According to medical experts, the symptoms are similar to cold or flu symptoms.
Amid rising sample requests in the wake of a fresh infection wave, Dr Arjun Dang, CEO of Dr Dangs Lab, said the laboratory is witnessing a surge in testing.
Speaking to ANI, Dr Dang stated that the number of samples has increased, 'There has been an increase in the number of sample requests that we are receiving. But this time, we are better prepared, more informed, and we have better surveillance tools. With the scientific tests that we have, we are in a good place from the preparedness perspective to face this effectively and minimise any kind of damage that the current wave might cause.'
He further said the circulating variants are subvariants of Omicron showing mild symptoms, 'We must understand that the current spreading variants are again a sublineage of the Omicron virus. Additionally, in states like Tamil Nadu and Gujarat, we have certain other sub-variants as well that have been named as Variants Under Monitoring, and these are basically of two types, that is, LF7 and NV.1.8.1. Currently, the cases that we are seeing are more transmissible. They can infect people easily, but again, from the severity perspective, till now, we have not seen any severe cases.'
'All of these are actually presenting as common cold and flu, and the usual symptoms that we have in any kind of common cold, even the hospitalisations, have been minimal,' Dang said.
Dr Arjun also said that majorly since few days testing has been increased, 'I think, may this month had started on a very low note with minimal cases, but I think in the past five to seven days is when we've seen a major uptake and now we are getting significantly high cases to test on a daily basis.'
Recently, in an Exclusive interview with ANI, Dr Rajiv Bahl, DG, ICMR, said the government is focusing on transmission, surveillance, and preparedness, but currently circulating variants have mild symptoms like Omicron. 'The government and health agencies are closely monitoring COVID-19 cases and taking necessary steps. Currently, the number of active cases is low, and most cases are limited to southern and western India. The government is focusing on three key factors. The rate of transmission and the rapidly increasing cases. Whether the virus is evading our natural and vaccine-induced immunity. Whether the current infections are more severe than before or have mild symptoms like Omicron.' (ANI)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
4 hours ago
- Business Standard
Senior citizens double down on super top-ups, drive 61% rise in portability
As medical costs rise, senior citizens are changing how they buy health insurance. More such citizens are purchasing policies earlier in their lives; they are adding top-ups, and even switching insurers for better value, according to data provided by Policybazaar. Almost six of 10 health insurance policies are bought by people aged 60 to 65, making it the most active bracket. The 66-70 segment is also seeing steady growth. About 65 per cent of policies bought by senior citizens were renewed in FY5 and one in three purchases were fresh, pointing to expanding coverage among families. Cost-saving strategies To manage premiums, senior citizens use tools like: 15-20 per cent opt for deductibles of Rs 2-3 lakh. Top-up purchases have almost doubled in three years, with one in three senior citizens choosing such offers to expand insurance cover Around 12 per cent shift to co-pay options at renewal, paying a small share of bills while insurers bear the bulk. Seniors seek flexible cover and add-ons Senior citizens prefer features that offer immediate and relevant insurance protection: Over 40 per cent now want cover for pre-existing conditions without waiting. Women lean towards OPD and wellness riders, while men prefer critical illness add-ons. Demand for domiciliary treatment has risen, especially after Covid-19. Portability rising As many as 61 per cent senior citizens have changed their insurers in two years for cheaper premiums or better service, according to Policybazaar. This shows growing financial awareness in evaluating long-term value, not just price. Urban-rural divide Insurance penetration is better in cities like Delhi, Bengaluru and Hyderabad, where seniors buy higher covers of Rs 10-25 lakh. Coverage in villages and towns is largely driven by government schemes, though Tier-II cities are slowly bridging the gap. Premium payment Nearly three in four premiums are funded by children or family members of senior citizens. Of these, 11 per cent come from children living abroad, highlighting the role of overseas support in ageing parents' healthcare. About 27 per cent of seniors, however, still pay premiums on their own. 'We're witnessing a significant shift in how India's senior citizens approach health insurance. Seniors are insuring earlier, buying larger covers and making smarter choices, whether through super top-ups, portability or Day-1 coverage,' said Siddharth Singhal, business head, health insurance, at Policybazaar.
News18
5 hours ago
- News18
Research is the way forward: ICMR DG
Last Updated: New Delhi, Aug 21 (PTI) Indian Council of Medical Research (ICMR) Director General Dr Rajiv Bahl Thursday said research is the way forward, and stronger systems can be built and knowledge can be generated by learning from each other's research ecosystems, which can be translated for the betterment of the health of people. The Department of Health Research (DHR) and the ICMR inaugurated a two-day regional meeting titled 'Health Research and Innovations in Public Health: Exchange of Good Practices across RESEARCH Platform'. Delivering the plenary address, Dr V K Paul, Member, NITI Aayog, commended the participating countries for their significant progress in advancing the health and well-being of their citizens. 'The progress we see across these countries is a testament to their commitment to health. There is tremendous scope for us to learn from each other, co-create research products and translate science into action. By working together, we can accelerate progress towards achieving Sustainable Development Goals across the region," said Dr Paul. Dr Bahl said, 'The issues we face are common to all of us, and it is time for our region to move towards shaping its own narrative. Research is the way forward, and by learning from each other's research ecosystems, we can build stronger systems, generate knowledge that reflects our realities, and translate it into better health for our people." The event, held at the Sushma Swaraj Bhawan, brought together senior representatives from Nepal, Sri Lanka, Bhutan and Timor-Leste to deliberate on strengthening health research systems, facilitate the exchange of good practices and promote cross-border collaboration in South and Southeast Asia. The meeting is part of the Regional Enabler for South and Southeast Asia Research for Health (RESEARCH) Platform, which aims to foster solidarity, knowledge-sharing, and collaboration among participating countries, the health ministry said in a statement. The representatives from Nepal, Sri Lanka, Bhutan and Timor-Leste also delivered opening remarks, drawing attention to the health concerns that affect their populations and the region as a whole, such as anaemia, maternal and child health, tuberculosis, vector-borne diseases and non-communicable diseases. They emphasised the vital role of governments in ensuring public trust in science, highlighted the importance of sustained investments in capacity building alongside expanding infrastructure, and reiterated their commitment to regional solidarity in advancing health research and innovations, the ministry's statement said. Over the next two days, the meeting will include deliberations on diverse aspects of health research systems, including governance structures, research financing, mechanisms for prioritising research agendas and approaches to ensuring transparency and ethics. The participating countries will also discuss strategies to foster medical technology innovations, translate research into policy and programmes, and strengthen collaboration across sectors and with international partners, the statement said. This first-of-its-kind gathering marks a significant milestone in fostering regional cooperation and knowledge-sharing in health research. By coming together under the RESEARCH Platform, the participating countries have signalled their intent to learn from one another, co-create solutions, and jointly harness the power of science and innovation to improve public health and accelerate progress towards universal health coverage, it said. PTI PLB KSS KSS view comments First Published: August 21, 2025, 17:15 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy. Loading comments...
Hindustan Times
5 hours ago
- Hindustan Times
How Generative AI can improve patient care
Artificial Intelligence (AI) tools are transforming industries, such as finance and banking, retail, and telecommunications, by boosting efficiency and quality. The potential of AI lies in its adaptability and customisation, which have vast benefits for health care management and clinical practice. Representational Image(Pixabay) While AI technologies in imaging, radiology, and precision medicine hold significant promise for transforming health care, their integration into the Indian health care system remains limited due to low levels of hospital digitalisation and a lack of widespread AI literacy. However, with the undeniable benefits offered by AI tools for patients and clinicians alike, adoption is gradually gaining momentum in the Indian health care landscape. The 2023 guidelines on ethical and responsible use of AI by Indian Council of Medical Research (ICMR) were a welcome step to pave the way for safe, human-centric AI integration. Generative AI demonstrates significant potential in health care by optimising medical workflows, supporting evidence-based clinical decision-making, and improving patient outcomes. The deployment of specialised, use-case-specific AI tools enables health care systems to enhance operational efficiency while advancing the quality of care. Hospitals are intricate ecosystems that demand seamless coordination among administrative staff, clinicians, surgeons, radiologists, nurses, and support services. Medical management teams are tasked with ensuring quality and safety, overseeing the synergy between different departments, and facilitating optimal resource utilisation. Adoption of electronic health records (EHR) and AI-optimized hospital information management systems can enable GenAI tools to create impact through strategic support. For instance, adoption of GAI-powered conversational chatbots is suitable and effective in various clinical settings. These chatbots can conduct pre-consultation interviews with patients, which saves time for both clinicians and patients. By capturing medical histories and relevant details in advance, they enable physicians to focus more on meaningful patient interaction during consultations. GAI-based clinical assistants also contribute significantly to tasks such as medicine reconciliation and auto-reporting for investigations, which can be vetted and approved by the treating physician. By automating tasks like test ordering, communication between departments becomes faster and less burdensome for doctors. Beyond administration, GenAI supports evidence-based medicine, transforming clinical decision support by enabling more dynamic, context-aware, and patient-centred care. GAI-powered Clinical Decision Support Systems (CDSS) works as a highly specialised search engine that draws on a database of only peer-reviewed, verified, and high-quality sources, conforming to strict medical guidelines and standards. This prioritises the Human-in-the-Loop (HITL) approach, where human expertise and knowledge to make critical decisions are supported by GAI capabilities.. Traditionally, clinicians relied on extensive textbooks or unverified online sources for medical research. Today, GAI-powered Clinical Decision Support Systems (CDSS) offer instant access to the latest, evidence-based clinical data, enabling personalised treatment planning with precision. While CDSS does not replace medical expertise, it enhances it--empowering doctors and nurses to make faster, better-informed decisions backed by verified sources and transparent citations, ultimately improving patient care. There's much that CDSS and GenAI can do, but their limits are clearly defined. The role of AI in health care will always be to support and enhance. Values like accountability, empathy, sensitivity, and compassion are the domain of human beings. AI tools for health care must be ethically designed and sensitively implemented with a non-negotiable focus on safety and quality, allowing health care professionals to do the best possible work they can. As GAI uptake increases and becomes more accessible, such tools have the potential to greatly benefit medical students, doctors in remote and underserved areas, ASHA workers, and community physicians – making health care more accessible, accurate, and patient-centric across India. This article is authored by Nimisha Goswami, director, content strategy, Elsevier.
